与社区居住的巴西老年人饮食多样性相关的因素
Ligiana Pires Corona1, Graziele Maria Silva1, Carolina Neves Freiria2
1School of Applied Sciences, University of Campinas, R. Pedro Zaccaria, 1300, Limeira 13484-350, Brazil.
Foods (Basel, Switzerland)
|November 9, 2024
概括
巴西的老年人通常饮食多样性较低. 收入和癌症诊断等因素对他们的饮食产生了积极的影响,而认知能力下降和久坐不动的生活方式则对其产生了负面影响.
科学领域:
- 老年学是指老年学的学科.
- 营养科学 营养科学
- 公共卫生 公共卫生
背景情况:
- 老年人面临着营养不良和单调饮食的重大风险.
- 评估饮食多样性是识别有风险人群的关键指标.
- 巴西的初级医疗保健服务服务于易受营养挑战的人口.
研究的目的:
- 调查巴西接受初级医疗保健的老年人饮食多样性.
- 为了确定与这一群体的饮食多样性相关的社会人口统计学,健康和生活方式因素.
主要方法:
- 一项涉及581名年龄在60岁及以上的参与者的横截面研究.
- 饮食多样性评分 (DDS) 是根据24小时的食物回忆计算的,将食物分为10组.
- 用于分析与DDS相关的因素的等级线性回归模型.
主要成果:
- 平均DDS为5.07 (±1.34),其中67.5%达到最低值 (≥5组).
- 更高的收入,先前的癌症诊断和偶尔的酒精消费与DDS增加有关.
- 认知能力下降,久坐不动的行为和衰老的厌食症与较低的DDS有关.
结论:
- 包括经济和社会结构在内的系统因素对于确保获得优质食品至关重要.
- 促进体育活动,解决药物滥用问题以及提供营养指导是必不可少的.
- 干预措施应考虑影响老年人饮食的社会经济,健康和生活方式因素的复杂相互作用.
相关概念视频
Lifestyle Factors and Health
37
Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
37
Factors Affecting Illness
4.2K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
4.2K
Factors Influencing Bioavailability: First-Pass Elimination
6.1K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.1K
Assessment of the Gastrointestinal System II: Health Perception Pattern
79
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
79
Factors Influencing Drug Absorption: Anatomical Parameters
182
Drug absorption involves the movement of drugs from the point of administration into the systemic circulation. Initially, Gastrointestinal (GI) motility propels the drug through the digestive tract and into the stomach. However, the stomach's high acidity and limited surface area restrict its role in drug absorption for most drugs. The drug then moves from the stomach to the small intestine via gastric emptying, which can be slowed by various factors, including interactions with other...
182
Factors Affecting Protein-Drug Binding: Patient-Related Factors
41
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
41


